Last Price
29.49
Today's Change
+0.43 (1.47%)
Day's Change
28.86 - 29.58
Trading Volume
225,758
Market Cap
951 Million
Shares Outstanding
32 Million
Avg Volume
442,614
Avg Price (50 Days)
32.27
Avg Price (200 Days)
34.88
PE Ratio
12.60
EPS
2.34
Earnings Announcement
20-Feb-2025
Previous Close
29.06
Open
29.13
Day's Range
28.86 - 29.58
Year Range
28.75 - 42.287
Trading Volume
225,758
1 Day Change
1.48%
5 Day Change
-2.96%
1 Month Change
-5.45%
3 Month Change
-23.34%
6 Month Change
-7.35%
Ytd Change
-5.57%
1 Year Change
-2.38%
3 Year Change
48.19%
5 Year Change
44.91%
10 Year Change
139.95%
Max Change
139.95%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.